SOLID Therapeutics is an early-stage oncology company spun out of CBMR at the University of Copenhagen. We are developing novel cancer therapeutics with dual mode of action targeting both cancer cells and immune cells to treat solid tumors.
| Website | https://www.solidtherapeutics.com |
| Employees | 5 (1 on RocketReach) |
| Phone | +45 27 39 67 75 |
| Industry | Biotechnology Research |
| Keywords | Oncology Therapeutics, Cancer Treatment, Immuno Oncology, Cancer Research, Cancer Immunotherapy, Solid Tumor Treatment, Oncology Research, Novel Cancer Therapies, Innovative Cancer Treatments, Targeted Cancer Therapy, Therapeutic Development, Biopharmaceutical, Biotechnology, Drug Development, Pharmaceutical Research, Clinical Trials |
| Competitors | Novartis, Amgen, Gilead Sciences, Moderna Therapeutics, BioMarin Pharmaceutical Inc., Ultragenyx Brasil, Sarepta Therapeutics, Spark Therapeutics, Inc., REGENXBIO Inc., NantKwest +36 more (view full list) |
Looking for a particular SOLID Therapeutics employee's phone or email?
1 people are employed at SOLID Therapeutics.